BioHarvest Sciences Inc. Common Stock (BHST) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
BHST Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, BioHarvest Sciences Inc. Common Stock (BHST) trades at a price-to-earnings ratio of -5.1x, with a stock price of $4.11 and trailing twelve-month earnings per share of $-0.68.
Compared to the Basic Materials sector median P/E of 23.4x, BHST trades at a 122% discount to its sector peers. The sector includes 125 companies with P/E ratios ranging from 2.0x to 144.2x.
Relative to the broader market, BHST trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BHST DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BHST P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $339M | 14.3Lowest | - | -60% | |
| $391M | 28.8 | 0.86Best | +51%Best | |
| $8B | 25.5 | 1.11 | -25% | |
| $2B | 14.4 | 3.85 | -29% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
See BHST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BHST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BHST vs LIN
Side-by-side business, growth, and profitability comparison vs Linde plc.
Start ComparisonBHST — Frequently Asked Questions
Quick answers to the most common questions about buying BHST stock.
Is BHST stock overvalued or undervalued?
BHST current P/E: -5.1x. 5-year average P/E: N/A. Percentile: N/A.
How does BHST's valuation compare to peers?
BioHarvest Sciences Inc. Common Stock P/E of -5.1x compares to sector median of 23.4x. The discount suggests lower growth expectations or higher risk.
What is BHST's PEG ratio?
BHST PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.